myotonic dystrophy research

Located around the United States, MDA’s new network provides a foundation for the conduct of clinical trials in MMD1 and MMD2

posted on January 23, 2013 - 10:00am
MDA has launched a new, five-center clinical research network focused on type 1 and type 2 myotonic muscular dystrophy (MMD1 and MMD2, also known as DM1 and DM2), with the principal goal of preparing for testing of new MMD treatments as they become available.

New content is being added every day. Please check back again.